Urology Group of Southern California — Los Angeles, California

Urology Group of Southern California is a clinical research site located in Los Angeles, California, United States 90017.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Urology Group of Southern California has participated in 14 clinical trials with 6 currently active.

Therapeutic areas: Urinary Bladder, Overactive, Overactive Bladder Syndrome, Hypogonadism.

Sponsors: Pfizer, Imbrium Therapeutics, TesoRx Pharma, LLC.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Urology Group of Southern California?

Urology Group of Southern California has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Urology Group of Southern California conducted?

Urology Group of Southern California has 14 clinical trials on record, with 6 currently active. Their work covers Urinary Bladder, Overactive, Overactive Bladder Syndrome, Hypogonadism.

Is Urology Group of Southern California accredited by Crixeo Health?

Yes — Urology Group of Southern California holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Urology Group of Southern California?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.